Megmazid-T Injection
Marketer
Ridhima Biocare
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Megmazid-T Injection
T-Megmazid Injection combines multiple medications to combat diverse bacterial infections. Its action inhibits microbial proliferation, halting infection spread. Administration requires a healthcare professional's oversight; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may reduce efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications before starting this treatment, including if you're pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't impair driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, proper nutrition, and hydration are recommended for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Primary Ingredients of Megmazid-T Injection
There is no text provided to rephrase.
Uses of Megmazid-T Injection
Infections caused by bacteria
Major Benefits of Megmazid-T Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Megmazid-T Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Megmazid-T Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Megmazid-T Injection works:
Megmazid-T Injection combines the antibiotic Ceftazidime with the beta-lactamase inhibitor Tazobactum. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby boosting Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Megmazid-T Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Megmazid-T Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Use of Megmazid-T Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administration of Megmazid-T Injection can potentially reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
Exercise caution when administering Megmazid-T Injection to individuals with impaired renal function. Dosage modification for Megmazid-T Injection might be necessary. Physician consultation is advised.
LiverCAUTION
For patients with severe hepatic impairment, administration of Megmazid-T Injection requires careful monitoring. Dosage modification of Megmazid-T Injection might be necessary. Physician consultation is advised.
What if you forget to take Megmazid-T Injection :
Omit a scheduled Megmazid-T Injection? Seek medical advice immediately.
Facts to Know About Megmazid-T Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently